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Recombinant infectious hematopoietic necrosis viruses induce protection for 
rainbow trout (Oncorhynchus mykiss).  
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 Infectious Hematopoietic Necrosis Virus (IHNV) and Viral Hemorrhagic 
Septicaemia Virus (VHSV) are rhabdoviruses that infect salmonids worldwide 
producing serious economic losses.  
Two recombinant IHN viruses were generated by reverse genetics. The Nv gene 
was replaced with the GFP gene (rIHNV GFP). Moreover the rIHNV-Gvhsv GFP had 
the G gene exchanged for that of the VHSV. No mortalities, external signs or 
histological lesions were observed in experimental infections conducted with the 
recombinant viruses. Neither the rIHNV GFP nor rIHNV-Gvhsv GFP was detected by 
RT-PCR after infection in any of the examined tissues from experimentally infected 
fish. 
 In order to assess the potential of the recombinant viruses as vaccines against the 
wild type viruses, rainbow trout were vaccinated with them by intraperitoneal injection 
and challenged 30 days later with virulent IHNV or VHSV. The GFP viruses provided 
protection against both wild type viruses. None of the recombinant viruses induced 
antibody production and the expression of interferon (IFNαβ) and interferon induced 
genes such as Mx protein and ISG-15, was not different to those of controls. The 
rIHNV-Gvhsv GFP did not inhibit the cellular apoptosis as it was observed in an IHNV 
inoculated fish cell line. 
These studies suggest that the recombinant rIHNV-Gvhsv GFP is a promising 
candidate to be used as an IHNV live recombinant vaccine and a good model to further 
study viral pathogenicity and the molecular bases of the protection against these 
infections. 
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Infectious Hematopoietic Necrosis (IHN) and Viral Hemorrhagic Septicaemia 
(VHS) are the most serious salmonid viral diseases with high negative impact on 
aquaculture (Wolf 1988, Winton 1991). Epizootics have been detected in wild fish 
populations, and outbreaks are common at hatcheries in North America, Europe and 
Asia, where the losses among juvenile fish can reach 90% of the production. The Idaho 
trout industry estimated that the annual losses caused by the virus are about 3 million 
USD (Bootland & Leong 1999). The causative agent of IHN and VHS are two 
Rhabdoviridae family members. They have a single-stranded RNA genome that 
encodes five structural proteins (Morzunov et al. 1995, Schütze et al. 1995) and a non-
virion protein NV (Kurath et al. 1985, Schütze et al. 1996). 
Due to the lack of effective strategies to control these diseases, IHNV and 
VHSV infections usually cause high mortalities. Although vaccination is the most 
suitable control method, there is only one available live attenuated vaccine for VHSV 
licensed in Germany since 1996 (P. Enzmann Tübingen) and a DNA IHNV vaccine 
licensed in Canada (Novartis). Moreover highly efficient IHNV and VHSV DNA 
vaccines have been developed (Anderson et al. 1996, Heppell et al. 1998) and are being 
tested in field trials. 
Reverse genetics have been recently used to generate modified rhabdoviruses 
that could be potential candidates to be used as live vaccines. Reverse genetics consists 
on the recovery of recombinant viruses from vaccinia-infected cells that are transfected 
with an expression plasmid coding for the full length antigenomic cDNA together with 
plasmids coding for the nucleoprotein (N), the phosphoprotein (P) and the RNA 
polymerase (L). This system has been applied to several rhabdoviral models (Schnell et 
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al. 1994, Lawson et al. 1995, Whelan et al. 1995, Biacchesi et al. 2000 a, b, Johnson et 
al. 2000, Ito et al. 2001).  
The recombinant viruses used in the present study had two of the six IHNV 
genome genes modified. One encodes the G protein related with this virus pathogenicity 
and capable of eliciting protective antibody production against various IHNV strains 
(Engelking & Leong 1989 a, b). The other is the NV protein whose function is not well 
known but it is able to enhance viral growth in cell culture (Kurath & Leong 1985). 
Changes in the viral genome might modify viral characteristics such as virulence and 
tissue tropism 
The IHNV genome has been shown to be extremely flexible to accommodate 
heterologous structural proteins. The complete IHNV G gene has been replaced by the 
VHSV G gene, recovering a recombinant virus expressing the VHSV G instead of 
IHNV G (Biacchesi et al. 2002). This virus was already shown to efficiently replicate in 
cell culture, and to be virulent for rainbow trout by bath infection. The replacement of 
the G protein by VHSV G protein (rIHNV-Gvhsv) did not modify the tropism or the 
lesions induced by viral infection (Romero et al. 2005). 
Kim et al. (1994), using a mAb directed against the IHNV-G protein, selected a 
G-mutant strain, RB-1 particularly attenuated and related the loss of virulence with G 
protein amino acid changes at position 78 and 218 and probably with other changes in 
the viral genome (Romero et al. 2005). As it was demonstrated by the successful 
recovery of recombinant virus expressing foreign genes instead of the NV gene, the NV 
protein was not essential for viral replication. A viral construction was created in which 
the entire NV open reading frame was deleted and replaced by the green fluorescent 
protein (GFP) encoding gene (Biacchesi et al. 2000 a). Using these mutants Novoa et al. 
(2006) reported the zebrafish as a suitable animal model to study VHSV infection and 
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immune (innate and adaptive) responses and a fish viral diseases vaccination model. 
The reverse genetics technique is a novel and highly useful methodology to generate 
attenuated viruses that may allow the study of the basic protective responses 
mechanisms.  
In order to evaluate the recombinant viruses potential as a live attenuated 
vaccines, two recombinant IHN viruses were investigated and tested in a vaccine trial. 
The recombinant virus rIHNV GFP, described by Biacchesi et al. (2000 a), has never 
been tested in experimental infections and vaccine trials. Morevover, a new 
recombinant virus (generated for this paper) rIHNV-Gvhsv GFP similar to the rIHNV-
Gvhsv described by Biacchesi et al. (2002), in which the NV gene was replaced by the 
GFP gene, has been also assayed for the first time.  
To the best of our knowledge, this is the first paper describing changes in the 
viral cycle, pathology and tissue tropism of both recombinant viruses. The protective 
response was characterized by determining antibody production, several antiviral genes 
expression levels and apoptosis induction. 
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Viruses and cell cultures. Recombinant rIHNV GFP and rIHNV-Gvhsv GFP 
(Biacchesi et al. 2000 a, b, 2002), were used in the present study. The non-structural NV 
gene was replaced with the green fluorescent protein (GFP) gene and the G protein gene 
was changed for that of VHSV in the rIHNV-Gvhsv GFP. The wild type (wt) virus 
strains used were French isolates IHNV 32/87 and the European VHSV 07-71 strain 
(Laurencin, 1987).
Viruses were replicated in the EPC fish epithelial cell-line, derived from 
common carp (Cyprinus carpio L.) (Tomasec & Fijan 1971) and in the RTG-2 cell line 
derived from rainbow trout gonad tissue (Wolf & Quimby 1962). Viral replication was 
carried out at 15ºC and the viral titer was calculated according to the protocol described 
by Reed and Müench (1938). RTG-2 and EPC cell lines stocks were cultured in Eagle’s 
minimum essential medium (MEM, Gibco) supplemented with 10% of foetal bovine 
serum (FBS), penicillin (100 IU ml-1), streptomycin (100 μg ml-1), buffered with 7.5% 
sodium bicarbonate and incubated at 20ºC.  
 
Fish. Rainbow trout (Oncorhynchus mykiss L.) from a commercial fish farm were 
acclimatised to laboratory conditions for 2 weeks. Experiments were performed in 50 l 
closed circuit tanks with aeration at 14ºC. Fish were fed daily with a commercial dry 
pellet food.  
 
Experimental infections. Six different experiments were performed to estimate the 
virulence of the IHNV recombinants by intraperitoneal (ip) injection. 270 fish of 4-7 g 
total mean weight, were inoculated per treatment (in each trial) with 100 μl of a 106 pfu 
ml-1 dilution of the different recombinants. As a positive control, IHNV and VHSV wild 
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types were included and a negative control group was injected with culture medium. 
External signs (nature and intensity) and mortalities were recorded every day for 30 
days after virus exposure. Fish were also kept in 50 l tanks with a closed circuit water 
system. The work was conducted following Good Laboratory Practices guidelines. 
Statistical analysis comparing infected and control groups were done using T-test 
(p<0.05). 
 
Histology. An experiment was conducted to study histological lesions induced by the 
recombinant viruses. Rainbow trout distributed into 30-fish groups (fish with mean total 
weight of 4-7 g) in 50 l tanks were intraperitoneally (ip) injected with 100 μl of each of 
the IHNV recombinants or with wild type IHNV as a positive control group (5x106 pfu 
ml-1). A negative control group was injected with culture medium. The evolution of the 
histological lesions was evaluated on 4 fish from each group at days 1, 3, 7 14 and 28 
post-infection. The muscle, kidney, liver, spleen and brain were sampled and processed 
for histology. The severities of the lesions were recorded using a grading system 
established for the most frequent kidney and liver lesions (Romero et al. 2005). 
Transversal sections of approximately 5 mm thick from the organs were excised, fixed 
in 4% buffered formalin, embedded in paraffin and stained with haematoxylin and 
eosin.  
 
Induction of cytopathic effect in vitro. Virus replication assay was done on EPC and 
RTG-2 cells. Confluent monolayers of cells on 25 cm2 tissue culture flasks (Falcon) 
were infected with 0.2 ml of the recombinant viruses (moi 1). After allowing 30 min for 
viral adsorption, cells were covered with 10 ml of culture medium containing 2% of 
FBS. The appearance of cytopatic effect (CPE) and morphological changes were 
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observed. In order to ensure that the cellular changes were induced by the viruses, a UV 
fluorescent microscopy (Nikon Eclipse TS100) was used to evaluate the fluorescent 
light emitted by the recombinant viruses with the GFP (rIHNV GFP and rIHNV-Gvhsv 
GFP). 
 
Viral distribution in vivo. The detection of the viral replication in vivo was assayed by 
a semi-nested RT-PCR. Trout groups (N=15, with a mean total weight of 5.5 g) were ip 
injected with 100 μl of either the wild IHNV (positive control group) or the different 
recombinants (2x106 pfu ml-1). After 1 and 3 days post-injection, three fish from each 
group were sampled and the kidney, liver and spleen removed. RNA extraction was 
performed using Trizol Reagent (Invitrogen) following the manufacturer indications. 
The reverse transcription and semi-nested PCR were performed following the procedure 
described by Miller et al. (1998).  
 
Immunization and virus challenge. Three trials were performed to study the 
protection induced by each recombinant virus against experimental challenges with 
pathogenic IHNV and VHSV. Trout groups (N=80, with a total mean weigh of 5,5 g) 
were ip inoculated with 100 μl of each recombinant (106 pfu ml-1). An additional group 
was mock infected with PBS (negative control group). 30 days after vaccination, fish 
were ip challenged with 100 μl injection containing 2x106 pfu ml-1 of the pathogenic 
wild type viruses, IHNV or VHSV. Mortalities were recorded 30 days post challenge. 
The vaccine efficacy was expressed as the fraction of the mortality that was prevented 
by the vaccination up to the end of the experiment (Relative Percent of Survival) (RPS 
= 1 - (% mortality in vaccinated group / % mortality in control group) x 100 (Jarp & 
Tverdal 1997). A T-test (p<0.05) was used to compare vaccinated and control results. 
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Antibody production. To determine the ability of the different IHN recombinant 
viruses to induce antibody production, rainbow trout (mean total weight 22 g) were ip 
injected with 250 μl solution containing 103 pfu ml-1 of each virus. Positive control 
groups were injected with IHNV or VHSV wild types. A non lethal infection was 
conducted (low viral dose) to avoid killing the fish but enough to induce the antibody 
production before the end of the experiment. Blood was drawn from the caudal vein 
after 4, 7 and 10 weeks of exposure to the viruses and clotted overnight. Plasma was 
obtained by centrifugation for 15 min at 500 xg in a refrigerated centrifuge, and was 
stored at –20ºC until antibody production was quantified by an enzyme-linked 
immunosorbent assay (ELISA) previously described (Romero et al. 2005). 
For the ELISA, 96 well-plates were coated overnight with IHNV (2x106 pfu ml-
1, 50 μl well-1) that was diluted in coating buffer (Na2CO3 0.0015 M, NaHCO3 0.03 M, 
pH 9.6) at 4ºC. All unbound sites were then blocked with phosphate buffered saline 
Tween-20 (PBS + 1% Tween-20) with 3% bovine serum albumin (BSA) for 1h at 37ºC. 
Plasma dilutions were performed in PBS-T + 1 % BSA and added in duplicate to 
precoated and blocked ELISA plates. After 1 h of incubation at 37ºC, plates were 
washed twice with PBS-T and incubated with a polyclonal anti-trout Ig (1G7) (Sánchez 
et al. 1991) diluted 1:500 in PBS-T for 2 h at room temperature, and revealed by a 
further 1 h incubation with a peroxidase conjugated anti-IgG antibody diluted 1:1000 in 
PBS. After two TBS-T washes, the enzyme substrate, orthophenylendiamine (OPD) 
(Sigma) was added and the reaction was stopped 20 min later with the addition of 3M 
sulphuric acid. The reaction intensity was measured by reading the optical density at 
492 nm and the antibody titter was calculated, taking a sample as standard (Shapiro et 
al., 1997). The antibody titer was represented as Units per ml. In the case of samples 
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taken from fish inoculated with rIHNV-Gvhsv GFP, an additional ELISA was 
performed to quantify antibodies against VHSV using the same protocol.  
 
Host gene expression. To study antiviral immune response related genes expression, 
new experimental infections were performed with the wild type IHNV and VHSV 
(positive control group) and the recombinant viruses rIHNV GFP and rIHNV-Gvhsv 
GFP. Fish were ip injected with 100 μl of the recombinant viruses (106 pfu ml-1) or PBS 
(negative control group) and kidney and liver were sampled at 24, 48 and 72 h post-
infection from 6 fish of each treatment. RNA extraction was performed using Trizol 
Reagent (Invitrogen). After DNAase treatment of RNAs (5 μg per sample), the reverse 
transcription was performed with the SuperScript II Reverse Transcriptase (Invitrogen) 
following manufacturer indications. Specific primers were designed using the 
Primer3.cgi v 0.2a software with available sequences in the Gene Bank database for 
IFNαβ and the interferon induced genes, Mx protein and ISG-15 protein (accession 
numbers: AF483529, AY788890, U47945). (ISG-15 primers (F: TCA GGT GTC AAT 
GGG AAC AA. R: TTT GGA CCT TGG CTT TGA AC), IFNαβ primers (F: GTC CTT 
TTC CCA ACA TCA CTT TA. R: TGC ACT GTA GTT CAT TTT TCT CA) and Mx 
primers (F: GGA CCC CCT GAA GAC CCA AAA G. R: ACT AAC TCT CCC TCC 
TCC AAC TCT). The β-actin gene was amplified as standard internal control with 
primers designed at our laboratory (accession number: AF157514. Primer F: AAA ACC 
AAA AGT TCA AAA TGG AAG. Primer R: GTT GAA GGT CTC AAA CAT AAT 
CTG G). The cycling protocol used was as follows: 94ºC for 5 min, 40 cycles of 94ºC 
for 30 s, 50ºC for 30 s and 72ºC for 1 min, followed by 72ºC for 7 min. The amplified 
fragments were 204, 285 and 584 bp long respectively. The PCR products were 
analysed in a 1% agarose gel and stained with ethidium bromide. Mx, IFNαβ and ISG-
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15 band intensity was determined by image analysis (Kodak software,1D 2.02) and 
divided by the respective β-actin band intensity to obtain a gen/β-actin ratio band 
intensity for each individual sample. Results are expressed as the mean value of the 
ratios of the gen/β-actin band intensity ± standard deviation. Statistical analysis between 
vaccinated and negative control groups were done using a T-test (p<0.05). 
 
Apoptosis assay. EPC confluent monolayers on 24 wells tissue culture plates (Falcon) 
were infected with 1 ml of 106 pfu ml-1of the recombinant viruses to study the induction 
of apoptosis. A negative control group and positive control group were included. The 
negative control group was treated with culture medium, meanwhile positive control 
group was treated with UV light for 30 min. Samples were taken at 24 and 48 h post 
treatment and measured by Annexin V-PE / 7AAD flow cytometry. Briefly, cells were 
washed twice with PBS and resuspended in 1x Binding buffer (10 mM Hepes/NaOH, 
pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) containing 5 µl of Annexin V-PE and 5 µl of 7-
aminoactinomycin D (7-AAD). Cells were incubated for 15 min at room temperature in 
the dark and measured in a FACscan flow cytometer using Cell Quest software (B&D, 
San Jose, CA).  
7-AAD (7-aminoactinomycin D) is a fluorescent DNA dye that selectively binds 
to GC regions of the DNA. During the cell death process, the plasma membrane is 
progressively altered and becomes permeable to the dye. The necrotic cells were 
recorded by the 7-AAD emission, detected in the FL-3 channel (>650 nm). During the 
apoptotic process the plasma membrane asymmetry is lost. The phosphatidylserine (PS) 
normally presented in the inner side of the membrane, translocates to the outer side of 
the plasma membrane, exposing it to the external cellular environment. The Annexin V-
PE is a 35-36 kDa phospholipid-binding protein with high affinity for PS. The apoptotic 
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cells were recorded by their PE emission, detected in the FL-2 channel (585 nm). The 
fluorescence emitted by the viral GFP protein was measured in the Fl-1 channel (530 
nm). This parameter recorded the percentage of infected cells. This technique not only 
provides information about the percentage of apoptotic and necrotic cells, but also 
estimates GFP recombinants infected cells. a T-test (p<0.05) was conducted to compare 
groups. 
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Experimental infections. The recombinant viruses (rIHNV GFP and rIHNV-Gvhsv 
GFP) pathogenicity was compared to IHNV and VHSV wild type in juvenile rainbow 
trout, by determining the disease signs and mortalities induced by each virus by 
intraperitoneal infections. Both wild type viruses (IHNV and VHSV) produced 100% of 
mortality at the end of the experiment (30 days). The mortalities began at day 1 and 
increased quickly to reach the maximum (100%) at day 21 and 24 respectively. The 
infection with the recombinant viruses induced low mortalities, less than 5%. In all the 
experiments (six different trials) these mortalities were significantly different from the 
mortalities induced by the wild type viruses (positive control groups), but similar to 
negative control group (Figure 1A). 
 No external clinical signs were observed in fish treated with the recombinant 
viruses, meanwhile dark coloration, distended visceral cavity, exophthalmia, pale gills 
and petechial haemorrhages at the base of the fins and abdomen was observed in fish 
infected with the wild type IHNV virus (positive control group) (Figure 1B). Fish 
infected with wt VHSV showed the same external clinical signs as those infected with 
wt IHNV. 
 
Histology. Histological analysis was performed to compare the lesions associated with 
each recombinant virus in different tissues. Although, as already described for IHNV 
wild type, the kidney and the liver are the main target organs, serious lesions were also 
found in all the recombinant virus infections. The kidney showed small haemorrhages in 
fish treated with rIHNV GFP (at day 7) and with rIHNV-Gvhsv GFP (at day 1 and 3), 
meanwhile the liver was only affected by the rIHNV-Gvhsv GFP at day 3. The spleen 
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and brain were not affected by the infection and some erythrocytes were observed 
between the muscular fibres (Figure 2). 
 
Induction of cytopathic effect in vitro. In the in vitro experiments, RTG-2 from trout 
and EPC from carp were used to propagate the recombinant viruses. The first 
morphological changes, detected as soon as 48h in with rIHNV-Gvhsv GFP infected 
cells resembled those induced by IHNV wild type (positive control group). Enlarged 
cells with their nuclei displaced to one side were observed in IHNV wild type and 
rIHNV-Gvhsv GFP infected cells (Figure 3B). The affected cells had a grape cluster 
aspect (Figure 3C). Association between the damaged cells and the appearance of 
fluorescence was observed by microscopy in rIHNV-Gvhsv GFP infected cells. Total 
CPE was observed at day 6 post-infection (Figure 3D). Although the cells infected with 
rIHNV GFP showed light green fluorescence in the cytoplasm, neither morphological 
changes nor a clear cytopathic effect was observed.  
 
Viral distribution in vivo. The viral replication in vivo was assayed by RT-PCR. No 
positive signal was found in recombinant viruses (rIHNV GFP and rIHNV-Gvhsv GFP) 
infected fish samples. Faint bands were observed in rIHNV GFP infected fish kidney at 
day 1, but were absent at day 3 (table 1). IHNV was clearly detected in all IHNV 
infected fish samples (positive control group). 
 
Protection experiments. A decrease in the cumulative mortality was observed in the 
group of rIHNV GFP and rIHNV-Gvhsv GFP infected fish in comparison with the 
mortality recorded in the negative control group (treated with PBS) infected with IHNV 
or VHSV 30 days after vaccination (figure 4 A and B respectively) 
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Mortality kinetics in the negative control group infected with IHNV or VHSV 
were similar to those described in section 3.1 (experimental infections). The mortalities 
in recombinant viruses vaccinated fish began at day 3 and increased slowly until the end 
of the experiment. IHNV induced a 97.3 (± 4.16) % of mortality in unvaccinated fish, 
meanwhile only a 29 (± 18.3) % and 36 (± 4) % of mortality was recorded respectively 
in the rIHNV GFP and rIHNV-Gvhsv GFP treated groups. The mortalities recorded in 
both vaccinated groups against IHNV were significantly different from the control 
group (p values 0.006 and 0.00006, respectively). By using rIHNV GFP and rIHNV-
Gvhvs GFP, the RPS values (percentage of protection) against IHNV were 70 % and 62 
% respectively.  
 Similar results were obtained in the vaccination experiments against VHSV. A 
91 (± 7.8) % of the unvaccinated fish died at the end of the experiment meanwhile only 
47.5 (± 3.5) % (using rIHNV GFP) and 27 (± 17.2) % (using rIHNV-Gvhsv) of the 
recombinant treated fish died. In this case the mortalities recorded in both vaccinated 
groups were also significantly different from the control group (p values 0.005 and 
0.004, respectively). The VHSV RPS values (percentage of protection) were 49 % when 
using rIHNV GFP and 61 % when rIHNV-Gvhvs GFP was used. No mortalities were 
detected in the negative non-infected control groups before and after the challenge. 
 
Antibody production. In order to clarify if the production of antibodies was correlated 
with the protection induced by the recombinant viruses against IHNV and VHSV, 
ELISA assays were performed (figure 5). The recombinant viruses induced an antibody 
production against the G protein included in their genomes. The rIHNV GFP induced a 
low antibody production against IHNV that did not increase with time as it was 
observed with the IHNV wild type (positive control group). No antibodies against 
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VHSV were detected. The kinetics of antibody production against VHSV in fish 
infected with rIHNV-Gvhsv GFP was similar to the kinetics induced by VHSV wild 
type (positive control group). At week 10 the antibody titer was as high as the titer 
induced by VHSV.  
 
Host gene expression. Interferon (IFNαβ) genes induction on recombinant viruses 
(rIHNV GFP and rIHNV-Gvhsv GFP) experimentally infected fish was studied and 
compared with the levels induced in fish treated with wild type viruses, IHNV and 
VHSV (positive control group), and with a negative control group (Figure 6). The 
infection of fish with IHNV induced an increase in the IFNαβ, Mx and ISG-15 
expression levels in liver and an increase in the Mx expression levels in kidney. The 
infection of fish with VHSV induced an increase of the expression levels of the same 
genes in kidney and only an increase in the IFNαβ expression levels in liver. 
The IFNαβ, and two genes coding for proteins induced by IFNαβ, Mx and an 
ubiquitin-like protein, ISG-15 expression profile were the same in fish treated with the 
two wild type viruses. A rapid increase of expression was observed from day 1 to day 2, 
followed by a decrease at day 3. IHNV induced maximum levels of these genes in the 
liver, meanwhile VHSV induced them in kidney. Variations were observed in gene 
expression levels in the negative control group. The GFP recombinant viruses did not 
induce an increased gene expression neither in the kidney nor in the liver. Although an 
IFNαβ expression up-regulation was observed in kidney and liver from rIHNV-Gvhsv 
GFP inoculated fish, they were always lower than those induced by IHNV and VHVS. 
The induction levels recorded in rIHNV GFP infected fish were always as low as the 
levels detected in the negative control group. 
 16
Apoptosis assay. The levels of early apoptosis were different in cells treated with the 
rIHNV-Gvhsv GFP, IHNV wild type and UV light. Using PE-Annexin V / 7-AAD two-
parameter flow cytometry, apoptotic, necrotic and living cells could be distinguished. 
Viable cells excluded 7-AAD and were negative for PE-Annexin V. Early apoptotic 
cells could be distinguished from necrotic cells by the lack of counterstaining with 7-
AAD. These cells excluded 7-AAD and binded PE-Annexin V to phosphatidyl serine 
exposed upon the cell surface. In contrast, necrotic cells were labelled with 7-AAD 
which stains dead cells independent of the cause of the cell death (apoptosis or any 
other) (Figure 7). 
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  The UV light induced the highest apoptosis levels at 24 and 48 h (16.5% and 
13% of apoptotic cells respectively) in comparison with the negative control group (less 
than 2%). Cells infected with the apathogenic rIHNV-Gvhsv GFP had low apoptosis 
levels at 24 h but showed around 13% of apoptosis, similar to UV-treated cells, at 48 h. 
It is important to point out that IHNV wild type induced apoptosis levels were 
significantly lower than those induced by the recombinant virus (less than 5%). The 
percentage of necrotic cells induced by IHNV was similar to the percentage induced by 
rIHNV-Gvhsv GFP (around 15%) but lower than the positive control (27%). Using the 
FL-1 channel, it was possible to detect 5% of cells infected with rIHNV-Gvhsv GFP at 
48h post-infection. The apoptosis in cells treated with the UV light and with IHNV was 
always lower than 0.5 %. 
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Recombinant viruses pathogenicity was assessed by determining the cumulative 
mortalities, evaluation of clinical external signs and histopathology from experimental 
infections. Fish infected with the wild type viruses (IHNV or VHSV) showed typical 
external signs (dark coloration, distended visceral cavity, exophthalmia and petechial 
haemorrhages at the base of the fins and abdomen) (Bootland & Leong 1999, Smail 
1999) and histopathological changes (Amend et al. 1969, Yasutake & Amend 1972, 
Wolf 1988). The recombinant viruses caused similar mortalities as the negative controls 
and the dead fish did not show external clinical signs or histopathological changes. The 
lack of mortalities and histopathological changes in rIHNV-Gvhsv GFP infected fish 
had been previously described in the zebrafish by Novoa et al. (2006). We have 
previously shown that modifications induced in the viral G protein gene can modify the 
mortality kinetics and the viral pathogenesis (Romero et al. 2005). Kim et al. (1994), 
analyzed a G-mutant strain, RB-1, that was particularly attenuated and its tissue 
distribution was markedly different. Although the NV gene is not necessary for 
accomplishing the viral cycle (Biacchesi et al. 2000 a, b) the interchange for the GFP 
gene could modify some viral characteristics. In our experiments, cell cultures infected 
with rIHNV GFP and rIHNV-Gvhsv GFP showed green fluorescence in the cytoplasm, 
but only those treated with rIHNV-Gvhsv GFP developed a clear cytopatic effect. 
Results obtained in experimentally infected cells with rIHNV GFP are in agreement 
with previous results obtained by Biacchesi et al. (2000 a) who detected low level of 
GFP expression in rIHNV GFP infected cells, through direct UV-light microscope 
observations. These authors did not describe the appearance of CPE and morphological 
changes in the cell line. The reason why modification introduced in the recombinant 
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viruses only suppressed the replication capacity of the rIHNV GFP is something that 
need further investigation. 
IHNV route of entry and progression has been studied in depth (Yamamoto 
1990, Yamamoto & Clermont 1990, Drolet et al. 1994) suggesting that IHNV infection 
progressed from gills into the circulatory system and from the oral region into the 
gastrointestinal tract and circulatory system. Romero et al. (2005) detected different 
virulent recombinant IHN viruses (rIHNV and rIHNV-Gvhvs) inoculated by 
intraperitoneal injection in liver, kidney and gills as early as 3 days post-infection. In 
the present work, rIHNV GFP and rIHNV-Gvhsv GFP were not detected in infected 
fish in kidney and liver by RT-PCR. This result suggests that tissue tropism might be 
affected by the introduced changes in the recombinant viruses. 
It is not evident if the introduction of the GFP gene or the substitution of the NV 
gene were the responsible of the changes observed in virulence and pathogenicity. It is 
important to point out that NV gene elimination was shown not to be required for 
pathogenesis of a novirhabdovirus by Alonso et al. (2004). 
High levels of protection were conferred by the GFP recombinant viruses against 
IHNV and VHSV. The heterologous protection has been previously described in 
vaccination trials against IHNV using different vaccination approaches. Engelking & 
Leong (1989 a, b), using purified RB-1 IHNV strain glycoprotein, recorded cross-
protective immunity against 5 biochemical types of IHNV. DNA vaccines encoding the 
viral G protein of different rhabdoviruses (IHNV, VHSV, SHRV and SVCV) elicited 
protective immunity against IHNV and VHSV (Kim et al. 2000, Lorenzen et al. 2002). 
The results obtained in the vaccination trials reflect the heterologous protection of 
rIHNV GFP and rIHNV-Gvhvs GFP against both IHNV and VHSV.  
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The timing of the heterologous protection with the recombinant viruses is 
interesting because it happened 30 days after treatment. IHNV vaccines based on DNA 
plasmids elicited high protection levels against this rhabdovirus but this phenomenon is 
transient, and often does not function at times as late as 30 days post-vaccination 
(LaPatra et al. 2001). It might be that the recombinant viruses provide protection against 
other species for a longer period because they replicate after infection (although not 
much by the data shown here), while the DNA vaccines do not. 
Antibody production is one of the mechanisms involved in the effectiveness of a 
vaccine. LaPatra et al. (1993) and Lorenzen & LaPatra (1999) showed that rainbow 
trout can produce specific and highly functional antibodies that are able to neutralise 
IHNV pathogenicity in vitro as well as in vivo. The kinetics and antibody production 
following an experimental infection with the recombinant viruses were not similar to 
those previously described for IHNV. The rIHNV GFP was able to induce specific 
IHNV antibodies but the titer did not increase with time. As expected, the rIHNV-
Gvhsv GFP was able to stimulate VHSV antibody production but the titer did not 
increase with time. The highest antibody titer was recorded at the tenth week. As shown 
in the results, the recombinant viruses did not induce a high antibody production that 
could explain the values of protection obtained. Probably other immune mechanism 
may be involved in the protection. 
A correlation between high antibody production, high levels of antiviral 
cytokines expression and protection has been described on several fish vaccination 
models (Boudinot et al. 1998, McLauchlan et al. 2003). Kim et al. (2000) using a DNA 
vaccine encoding the viral glycoprotein, correlated an early, non-specific antiviral 
protection with high levels of Mx protein in the kidney and liver, and they proposed that 
the initial IFNαβ induction was the basis of the protection. Actually, the critical role for 
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a type I interferon-like response in early anti-viral defence against IHNV has been 
confirmed by using quantitative real-time reverse transcriptase PCR methodology 
(Purcell et al. 2004, Acosta et al. 2005, Overturf &LaPatra 2006). The treatment with 
the GFP recombinant viruses, did not induce a significant antiviral gene expression 
neither in the kidney nor in the liver and the levels recorded were always as low as the 
levels obtained in control group. Similar expression profiles were obtained by Novoa et 
al. (2006) on rIHNV-Gvhvs GFP infected zebrafish. Our results supports the idea that 
there is not an evident implication of the IFNαβ pathway in the cross-protection 
observed so long after the vaccination with the GFP recombinant viruses (rIHNV GFP 
and rIHNV-Gvhvs GFP) (30 days) and other immune mechanisms appears to be 
implied. 
 Recent studies have shown that apoptosis may play an important role in many 
viral infections (Thoulouze et al. 1997, Gadaleta et al. 2002, Blaho 2003, 2004). Cell 
death due to rhabdovirus infection has been considered to result from necrosis following 
cell membrane damage caused by the budding virions (Wolf 1988). Apoptosis was 
involved on the cell death caused by rhabdovirus on different cell lines (Björklund et al. 
1997, Chiou et al. 2000, Du et al. 2004) and tissues (Eléouët et al. 2001). Recent studies 
have indicated that high virulent viruses may use one or more strategies to inhibit 
apoptosis, including the inhibition of transcription factors and the caspase activation to 
complete their viral cycle before programmed cell death (Fazakerley & Allsopp 2001, 
Liacarta & Harty 2003) Morimoto et al. (1999) compared the pathogenicity and the 
ability of apoptosis induction of two variants of rabies virus in primary neuron cultures, 
showing that the less pathogenic variant had a high level of G protein expression and 
induced significantly more apoptosis in infected cells than the more pathogenic one. 
The down regulation of G protein expression in neuronal cells contributed to rabies 
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virus pathogenesis by preventing apoptosis. Our results were in agreement with this. 
rIHNV-Gvhsv GFP induced higher apoptosis levels than the IHNV wild type. It is 
possible that the protection conferred by rIHNV-Gvhsv GFP against IHNV and VHSV 
could be related with an increase of the apoptosis which avoid the spread of the virus. 
This modification explains the limited capacity to replicate in fish tissues. 
 Our results suggest that reverse genetics is a powerful tool for the generation of 
modified viruses that could be used as vaccines. Based on the results obtained in 
challenge experiments the recombinant virus rIHNV-Gvhsv GFP is a promising life 
vaccine against fish rhabdoviruses. On the other hand the low antibody titter and 
antiviral cytokine expression can not explain the high levels of protection in 
experimental challenge. Further research is needed in order to clarify the involved 
mechanisms, not only immune but may be other cellular responses such as apoptosis. 
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     Liver     Kindey    Spleen 
   D1 D3  D1 D3  D1 D3 
IHNV   + + + + + +  + + + + + +  + + + + + + 
rIHNV GFP  - - - - - -  ± ± - - - -  - - - - - - 
rIHNV-Gvhsv GFP - - - - - -  - - - - - -  - - - - - - 
 
 
Table 1: Detection of wild-type IHNV and recombinant viruses by RT-PCR. Each 
symbol represents the result obtained in organs from different fish. (-) negative sample. 
(±) light band observed in the agarose gel. (+) positive sample. 
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Figure 1: (A) Cumulative mortality from intraperitoneal injection experiments 
(representative results from one experiment chosen from the six conducted). Mortality 
of wild type viruses (100% of mortality) was significantly different from the mortalities 
induced by the recombinant viruses. Neither the groups treated with the recombinant 
viruses, nor the negative control group reached 5% of mortality at the end of the 
experiment. (B) Clinical signs observed in fish infected with IHNV wild type. 
Distended visceral cavity, petechial haemorrhages at the base of the fins and abdomen 
and exophthalmia were observed in fish treated with IHNV (“I” in figure). Control fish 
and fish treated with the recombinant viruses did not show any clinical sign (“C” in 
figure). 
 
Figure 2: Main lesions observed in infected fish with recombinant viruses. (A, B and C) 
kidney, liver and muscle respectively from negative non-infected fish. (D, E and F) 
lesions induced in fish experimentally infected with IHNV (positive control group). 
Kidney (D) and liver (E) showed extended haemorrhages and necrotic areas mainly at 
day 4-7. Some fish showed histological changes in the muscle al day 7 pi (F). (G, H and 
I) lesions observed in rIHNV GFP infected fish. Small haemorrhages were observed in 
the kidney mainly at day 7 post infection (G). No lesions were observed in the liver (H) 
and brain (I). rIHNV Gvhsv GFP induced small haemorrhages in kidney (J) and liver 
(K) at the beginning of the infection and occasionally, erythrocytes between the 
muscular fibres were observed at the end of the infection (L). H&E staining. Scale bar 
40 μm. 
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Figure 3: Cytopathic effect and morphological changes on recombinant viruses infected 
EPC cell line light microscopy (A, B, C and D) and UV microscopy (E, F, G and H). A 
and E showed the negative control group without CPE by light and UV microscopy. B, 
C and D showed morphological changes in the cell culture at 1, 3 and 6 days post 
infection with the rIHNV-Gvhsv GFP. Neither morphological changes nor clear 
cytopathic effect was observed in rIHNV GFP infected cell lines. Similar results were 
obtained on the RTG-2 cell line. 
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Figure 4: Cumulative mortality obtained after 30 days post-vaccination with rIHNV 
GFP and rIHNV-Gvhsv GFP and posterior experimental challenge with IHNV (A) and 
VHSV (B). (*) Significant differences observed by using T-test (p<0.05).  
 
Figure 5. Antibody production against the different recombinant viruses. No production 
was detected in the control group against IHNV and VHSV. The recombinant viruses 
induced antibody production against the G protein. Each bar represents the mean and 
SD of 4 serum samples.  
 
Figure 6: Expression of antiviral genes in kidney and liver after 24, 48 and 72 h post-
treatment with rIHNV GFP, rIHNV-Gvhs GFP and the wild type viruses, IHNV and 
VHSV. IHNV induced maximum expression levels in liver, meanwhile VHSV induced 
them in kidney. The induction levels recorded in fish infected with rIHNV GFP and 
rIHNV-Gvhs GFP were always as low as the levels obtained in negative control group. 
Each bar represented the mean and SD of 9 fish. (*) T-test (p<0.05). 
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Figure 7: Percentage of early apoptotic cells (Annexin-V +/ 7-AAD-) and necrotic cells 
(Annexin-V -/ 7-AAD+) with different treatments. The apoptotic levels induced by 
rIHNV-Gvhsv GFP were similar to those induced by UV light at 48 h meanwhile the 
values obtained in IHNV wild type infected cells were lower than 5%. The necrotic 
levels recorded in cells treated with IHNV and rIHNV-Gvhsv GFP were similar, but 
always lower than the levels obtained in UV treatment. (*) T-test (p<0.05). 
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